The latest news from CPCT
Updates on our studies, publications and the upcoming Stelvio for Life event.
News in chronological order
Looking ahead: Stelvio for Life 2027
In 2027 the Stelvio for Life event returns: a sporting challenge on the legendary Stelvio pass where participants raise funds for CPCT research by cycling, running or hiking. Every euro goes in full to CPCT. To enrol, sponsor or learn more, visit stelvioforlife.nl.
DRUP in Nature: podcast on the first 1,610 treated patients
In a recent Nature publication, researchers report on the first 1,610 patients treated within the DRUP study. An accompanying podcast discusses the findings and their implications for precision medicine. Read the article on Nature.com and listen to the podcast alongside. See also the news items from the NKI and LUMC.
European precision medicine via PRIME-ROSE
PRIME-ROSE scales the DRUP model across ten European countries, giving more patients with metastatic cancer access to targeted therapies based on the molecular profile of their tumor. The latest updates are available on the News page of the PRIME-ROSE website.
Strengthening collaboration through research exchange
Researchers exchange knowledge and experience between PRIME-ROSE partners to strengthen collaboration.
ASCO 2026PRIME-ROSE at ASCO 2026: advancing collaboration in precision oncology
At ASCO 2026, PRIME-ROSE presents progress on European collaboration in precision oncology.
MeetingMid-term meeting held at Centre Léon Bérard in Lyon
Partners from ten European countries convened in Lyon for the PRIME-ROSE consortium's mid-term evaluation.
The Dark Genome: interview with Prof. Bas van Steensel
The BEACON consortium unravels the hidden codes in the dark genome — the 97% of our DNA that contains no genes. Using large-scale measurement methods and artificial intelligence, the consortium is making the effects of DNA variation predictable, to better estimate who is at increased risk of cancer. In the interview below, lead researcher Prof. Bas van Steensel explains more about this groundbreaking work.
10 years of CPCT, now available on demand
An extensive panel of contributors reflects on the successes and lessons learned from ten years of CPCT, in collaboration with MEDtalks.